Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases

211Citations
Citations of this article
262Readers
Mendeley users who have this article in their library.

Abstract

Inflammation is associated with the development of diseases characterized by altered nutrient metabolism. Although an acute inflammatory response is host-protective and normally self-limited, chronic low-grade inflammation associated with metabolic diseases is sustained and detrimental. The resolution of inflammation involves the termination of neutrophil recruitment, counterregulation of proinflammatory mediators, stimulation of macrophage-mediated clearance, and tissue remodeling. Specialized proresolving lipid mediators (SPMs)-resolvins, protectins, and maresins-are novel autacoids that resolve inflammation, protect organs, and stimulate tissue regeneration. Here, we review evidence that the failure of resolution programs contributes to metabolic diseases and that SPMs may play pivotal roles in their resolution. © 2014 Elsevier Inc.

Cite

CITATION STYLE

APA

Spite, M., Clària, J., & Serhan, C. N. (2014, January 7). Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metabolism. https://doi.org/10.1016/j.cmet.2013.10.006

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free